Triple
T5932247
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ICH |
E131963
|
entity |
| Predicate | hasFoundingIndustryAssociation |
P66982
|
FINISHED |
| Object |
European Federation of Pharmaceutical Industries and Associations
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association representing the research-based pharmaceutical industry in Europe, advocating for policies that support innovation, patient access to medicines, and a competitive life sciences sector.
|
E555144
|
NE FINISHED |
How this triple was built (5 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Federation of Pharmaceutical Industries and Associations | Statement: [ICH, hasFoundingIndustryAssociation, European Federation of Pharmaceutical Industries and Associations]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: European Federation of Pharmaceutical Industries and Associations Context triple: [ICH, hasFoundingIndustryAssociation, European Federation of Pharmaceutical Industries and Associations]
-
A.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
D.
General Pharmaceutical Council
The General Pharmaceutical Council is the independent regulator for pharmacists, pharmacy technicians, and pharmacy premises in Great Britain, setting standards for education, training, and professional practice.
-
E.
Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: European Federation of Pharmaceutical Industries and Associations Triple: [ICH, hasFoundingIndustryAssociation, European Federation of Pharmaceutical Industries and Associations]
Generated description
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association representing the research-based pharmaceutical industry in Europe, advocating for policies that support innovation, patient access to medicines, and a competitive life sciences sector.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: European Federation of Pharmaceutical Industries and Associations Target entity description: The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association representing the research-based pharmaceutical industry in Europe, advocating for policies that support innovation, patient access to medicines, and a competitive life sciences sector.
-
A.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
D.
General Pharmaceutical Council
The General Pharmaceutical Council is the independent regulator for pharmacists, pharmacy technicians, and pharmacy premises in Great Britain, setting standards for education, training, and professional practice.
-
E.
Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
- F. None of above. chosen
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasFoundingIndustryAssociation Context triple: [ICH, hasFoundingIndustryAssociation, European Federation of Pharmaceutical Industries and Associations]
-
A.
cityIndustryAssociation
Indicates an associative relationship between a city and an industry, such as the industry being present, active, or economically significant in that city.
-
B.
foundingIndustry
Indicates the industry or sector in which an entity was originally founded or began its primary operations.
-
C.
containsIndustry
Indicates that one entity includes or encompasses a particular industry within its scope, structure, or operations.
-
D.
hasIndustrialSector
Indicates that an entity is associated with, operates in, or belongs to a particular industrial sector or branch of economic activity.
-
E.
hasEconomicOrganization
Indicates that an entity possesses, is associated with, or participates in a specific economic organization or institutional economic structure.
- F. None of above. chosen
Provenance (7 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c0085b75e88190a632f9691f9da48b |
completed | March 22, 2026, 3:18 p.m. |
| NER | Named-entity recognition | batch_69c03f26f51881908cc253fe5775a1fc |
completed | March 22, 2026, 7:12 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c0c064d2a4819096085668182cfde1 |
completed | March 23, 2026, 4:24 a.m. |
| NEDg | Description generation | batch_69c0c109b3288190928dc4539a2872c2 |
completed | March 23, 2026, 4:26 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69c0c1f6fe60819080a00976740b6a9c |
completed | March 23, 2026, 4:30 a.m. |
| PD | Predicate disambiguation | batch_69c03355caf08190b960563a1aed23f9 |
completed | March 22, 2026, 6:22 p.m. |
| PDg | Predicate description generation | batch_69c03f23dd20819089dbf0de0d913602 |
completed | March 22, 2026, 7:12 p.m. |
Created at: March 22, 2026, 4 p.m.